Evidence map›Paper›PMID 32711093›Full record

ArticleJournal of the American Academy of Dermatology2021

Narrow excision margins are appropriate for Merkel cell carcinoma when combined with adjuvant radiation: Analysis of 188 cases of localized disease and proposed management algorithm.

Erica S Tarabadkar, Teresa Fu, Kristina Lachance, Daniel S Hippe, Thomas Pulliam, Hannah Thomas, Janet Y Li, Christopher W Lewis, Coley Doolittle-Amieva, David R Byrd and 3 more

Abstract read
In one paragraph

Article in Journal of the American Academy of Dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Review
  4. Article
  5. [Merkel cell carcinoma: current surgical approaches and multidisciplinary treatment].Revista medica del Instituto Mexicano del Seguro Social · 2026
    Review
  6. Article
  7. Merkel cell carcinoma: long-term outcomes after radiotherapy treatment.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Primary tumor site for localized Merkel cell carcinoma drives different management strategies without impacting oncologic outcomes.Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2023
    Article
  14. The Evolving Treatment Landscape of Merkel Cell Carcinoma.Current treatment options in oncology · 2023
    Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Erica S TarabadkarDepartment of Medicine, Division of Dermatology, University of Washington, Seattle, Washington; Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia.
Teresa FuDepartment of Medicine, Division of Dermatology, University of Washington, Seattle, Washington; Palo Alto Medical Foundation, Palo Alto, California.
Kristina LachanceDepartment of Medicine, Division of Dermatology, University of Washington, Seattle, Washington.
Daniel S HippeDepartment of Radiology, University of Washington, Seattle, Washington.
Thomas PulliamDepartment of Medicine, Division of Dermatology, University of Washington, Seattle, Washington.
Hannah ThomasDepartment of Medicine, Division of Dermatology, University of Washington, Seattle, Washington.
Janet Y LiSoutheast Dermatology, Houston, Texas.
Christopher W LewisDepartment of Medicine, Division of Dermatology, University of Washington, Seattle, Washington.
Coley Doolittle-AmievaDepartment of Medicine, Division of Dermatology, University of Washington, Seattle, Washington.
David R ByrdDepartment of Surgery, Division of Surgical Oncology, University of Washington, Seattle, Washington.
Jeremy T KamppDepartment of Medicine, Division of Dermatology, University of Washington, Seattle, Washington.
Upendra ParvathaneniDepartment of Radiation Oncology, University of Washington, Seattle, Washington.
Paul NghiemDepartment of Medicine, Division of Dermatology, University of Washington, Seattle, Washington. Electronic address: pnghiem@uw.edu.

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
Understand & overcome resistance to PD-1P01CA225517 · NCI · UNIVERSITY OF WASHINGTON · PI Cecilia C Yeung · 2019 to 2026
$22.7M
Interdisciplinary Tranining in Cancer ResearchT32CA080416 · NCI · UNIVERSITY OF WASHINGTON · PI STODDARD, BARRY L. · 1998 to 2023
$9.7M
Viral oncoprotein targeted immune therapy for Merkel cell carcinomaR01CA176841 · NCI · UNIVERSITY OF WASHINGTON · PI NGHIEM, PAUL · 2013 to 2016
$2.6M
Pathogenetic and prognostic studies for improved therapy of Merkel cell carcinomaK24CA139052 · NCI · UNIVERSITY OF WASHINGTON · PI NGHIEM, PAUL · 2009 to 2018
$1.8M
Exhaustion mechanisms in Merkel cell polyomavirus-specific T cellsF30CA254168 · NCI · UNIVERSITY OF WASHINGTON · PI PULLIAM, THOMAS · 2020 to 2023
$168k
NCI NIH HHS F30 CA254168NCI NIH HHS K24 CA139052NCI NIH HHS P01 CA225517NCI NIH HHS P30 CA015704NCI NIH HHS R01 CA176841NCI NIH HHS T32 CA080416
6 · The paper itself

Abstract

backgroundMerkel cell carcinoma (MCC) management typically includes surgery with or without adjuvant radiation therapy (aRT). Major challenges include determining surgical margin size and whether aRT is indicated.

objectiveTo assess the association of aRT, surgical margin size, and MCC local recurrence.

methodsAnalysis of 188 MCC cases presenting without clinical nodal involvement.

resultsaRT-treated patients tended to have higher-risk tumors (larger diameter, positive microscopic margins, immunosuppression) yet had fewer local recurrences (LRs) than patients treated with surgery only (1% vs 15%; P = .001). For patients who underwent surgery alone, 7 of 35 (20%) treated with narrow margins (defined as ≤1.0 cm) developed LR, whereas 0 of 13 patients treated with surgical margins greater than 1.0 cm developed LR (P = .049). For aRT-treated patients, local control was excellent regardless of surgical margin size; only 1% experienced recurrence in each group (1 of 70 with narrow margins ≤1 cm and 1 of 70 with margins >1 cm; P = .56). LIMITATIONS: This was a retrospective study.

conclusionsAmong patients treated with aRT, local control was superb even if significant risk factors were present and margins were narrow. We propose an algorithm for managing primary MCC that integrates risk factors and optimizes local control while minimizing morbidity.

Indexed as

AgedAged, 80 and overCarcinoma, Merkel CellCritical PathwaysDermatologic Surgical ProceduresDisease-Free SurvivalFemaleFollow-Up StudiesHumansMaleMargins of ExcisionMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingPractice Guidelines as TopicRadiotherapy, Adjuvantadjuvant radiationcontroversy, margin sizeexcisionlocal diseaselocal recurrenceMerkel cell carcinomanonmelanoma skin cancerradiationradiation therapysurgical margins

Identifiers

PMID32711093
PMCPMC7855019

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.